Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15324783
[patent_doc_number] => 20200002721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => EXPRESSION VECTORS COMPRISING CHIMERIC CYTOMEGALOVIRUS PROMOTER AND ENHANCER SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 16/372738
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372738
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372738 | EXPRESSION VECTORS COMPRISING CHIMERIC CYTOMEGALOVIRUS PROMOTER AND ENHANCER SEQUENCES | Apr 1, 2019 | Abandoned |
Array
(
[id] => 19181229
[patent_doc_number] => 11987812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Population of CD3-negative cells that express chemokine receptor and cell adhesion molecule, use of the same, and method for producing the same
[patent_app_type] => utility
[patent_app_number] => 17/041061
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 13200
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041061 | Population of CD3-negative cells that express chemokine receptor and cell adhesion molecule, use of the same, and method for producing the same | Mar 25, 2019 | Issued |
Array
(
[id] => 14926367
[patent_doc_number] => 20190298821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => Nucleic Acids for Treatment of Peanut Allergies
[patent_app_type] => utility
[patent_app_number] => 16/355785
[patent_app_country] => US
[patent_app_date] => 2019-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16355785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/355785 | Nucleic Acids for Treatment of Peanut Allergies | Mar 16, 2019 | Abandoned |
Array
(
[id] => 14868577
[patent_doc_number] => 20190284530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/354100
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/354100 | Gene-regulating compositions and methods for improved immunotherapy | Mar 13, 2019 | Issued |
Array
(
[id] => 14744041
[patent_doc_number] => 20190255194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/289947
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 222149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289947 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Feb 28, 2019 | Abandoned |
Array
(
[id] => 17875804
[patent_doc_number] => 11447807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing
[patent_app_type] => utility
[patent_app_number] => 16/288200
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 22156
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288200 | Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing | Feb 27, 2019 | Issued |
Array
(
[id] => 14498069
[patent_doc_number] => 20190192689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/286400
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16286400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/286400 | Lipid nanoparticle compositions and methods for mRNA delivery | Feb 25, 2019 | Issued |
Array
(
[id] => 17453240
[patent_doc_number] => 11268086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
[patent_app_type] => utility
[patent_app_number] => 16/279941
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 80
[patent_no_of_words] => 100609
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279941
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279941 | CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10) | Feb 18, 2019 | Issued |
Array
(
[id] => 16612144
[patent_doc_number] => 20210030797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 16/967375
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -152
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967375 | Methods for allogenic hematopoietic stem cell transplantation | Feb 6, 2019 | Issued |
Array
(
[id] => 16776637
[patent_doc_number] => 20210113714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => USE OF PCBP1 TO TREAT HYPERPROLIFERATIVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/967507
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967507 | Use of PCBP1 to treat hyperproliferative disease | Feb 4, 2019 | Issued |
Array
(
[id] => 15178847
[patent_doc_number] => 20190360015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => ANTIBODY COMPOSITION-PRODUCING CELL
[patent_app_type] => utility
[patent_app_number] => 16/260341
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16260341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/260341 | ANTIBODY COMPOSITION-PRODUCING CELL | Jan 28, 2019 | Abandoned |
Array
(
[id] => 16696931
[patent_doc_number] => 10947514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Adeno-associated-virus Rep sequences, vectors and viruses
[patent_app_type] => utility
[patent_app_number] => 16/254758
[patent_app_country] => US
[patent_app_date] => 2019-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 34
[patent_no_of_words] => 30609
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254758 | Adeno-associated-virus Rep sequences, vectors and viruses | Jan 22, 2019 | Issued |
Array
(
[id] => 15405183
[patent_doc_number] => 20200022913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/242704
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16242704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/242704 | Liposomal particles, methods of making same and uses thereof | Jan 7, 2019 | Issued |
Array
(
[id] => 14567005
[patent_doc_number] => 20190211109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => CHRONIC CAR TREATMENT FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/240382
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240382 | CHRONIC CAR TREATMENT FOR CANCER | Jan 3, 2019 | Abandoned |
Array
(
[id] => 18642431
[patent_doc_number] => 11766484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Exosome vessels for delivery of molecular cargo
[patent_app_type] => utility
[patent_app_number] => 16/239052
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9965
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16239052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/239052 | Exosome vessels for delivery of molecular cargo | Jan 2, 2019 | Issued |
Array
(
[id] => 14836793
[patent_doc_number] => 20190276797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHODS AND COMPOSITIONS RELATED TO INDUCED SENSORY NEURONS
[patent_app_type] => utility
[patent_app_number] => 16/232515
[patent_app_country] => US
[patent_app_date] => 2018-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16232515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/232515 | METHODS AND COMPOSITIONS RELATED TO INDUCED SENSORY NEURONS | Dec 25, 2018 | Abandoned |
Array
(
[id] => 14849825
[patent_doc_number] => 10413618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Lipid nanoparticle compositions and methods for mRNA delivery
[patent_app_type] => utility
[patent_app_number] => 16/233031
[patent_app_country] => US
[patent_app_date] => 2018-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17823
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16233031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/233031 | Lipid nanoparticle compositions and methods for mRNA delivery | Dec 25, 2018 | Issued |
Array
(
[id] => 15147677
[patent_doc_number] => 20190352316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/222740
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16222740
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/222740 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | Dec 16, 2018 | Issued |
Array
(
[id] => 18187561
[patent_doc_number] => 11578130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Regulatable chimeric antigen receptor
[patent_app_type] => utility
[patent_app_number] => 16/210480
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 91
[patent_no_of_words] => 123179
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16210480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/210480 | Regulatable chimeric antigen receptor | Dec 4, 2018 | Issued |
Array
(
[id] => 14156611
[patent_doc_number] => 20190105408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => METHOD FOR THE TREATMENT OF MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 16/208144
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208144 | Method for the treatment of malignancies | Dec 2, 2018 | Issued |